Investigation of the gut microbiota and adverse reactions associated with the combined bifidobacterium, lactobacillus, enterococcus and bacillus cereus tablets and rabeprazole in patients suffering from gastroesophageal reflux. Pharm Pract (Granada) [Internet]. 2026 Jan. 9 [cited 2026 Apr. 16];23(4):1-7. Available from: https://pharmacypractice.org/index.php/pp/article/view/3225